Jump Financial, LLC Verona Pharma PLC Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.46 - $30.16 $2.6 Million - $5.08 Million	-168,438 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$11.48 - $17.02 $1.76 Million - $2.62 Million	153,709 Added 1043.58%	168,438 $2.44 Million
Q1 2024 May 13, 2024	BUY	$15.3 - $20.24 $51,698 - $68,390	3,379 Added 29.77%	14,729 $236,000
Q4 2023 Oct 21, 2024	SELL	$11.94 - $20.47 $1.88 Million - $3.22 Million	-157,088 Reduced 93.26%	11,350 $225,000
Q4 2023 Feb 07, 2024	BUY	$11.94 - $20.47 $135,519 - $232,334	11,350 New	11,350 $225,000
Q4 2022 Feb 13, 2023	BUY	$9.84 - $26.13 $34,400 - $91,350	3,496 Added 8.57%	44,296 $1.16 Million
Q3 2022 Nov 07, 2022	BUY	$4.14 - $13.59 $168,912 - $554,472	40,800 New	40,800 $417,000

168

68.7M

704K

685K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $3.27B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.